[ad_1]
Life Insurance coverage Corp of India’s (LIC) holding in pharmaceutical firm Dr Reddy’s Laboratories has crosses 5.65% as on 15 June.
The company’s shareholding in Dr Reddy’s Lab has elevated from 60,64,345 to 93,96,91,801 fairness shares, or from 3.644% to five.646% of the paid-up capital of the corporate, LIC stated in a regulatory submitting on Thursday.
Whereas sharing additional particulars about the price of acquisition or the worth at which the shares had been acquired, LIC stated the holding elevated by 2.002% between 3 September, 2021 to fifteen June, 2022 at a mean value of ₹4,670.46 per share.
The corporate assertion additionally stated that the acquisition wouldn’t fall inside associated social gathering transaction(s) and the promoter / promoter group / group corporations have no real interest in the entity being acquired.
LIC has just lately elevated its stake in Hindustan Unilever Ltd, Hero MotoCorp and non-banking finance firm Capri World Capital via open market purchases over the previous couple of months.
The life insurer’s shareholding in Hero MotoCorp has elevated from 1,83,10,233 to 2,24,91,571 fairness shares, or from 9.163% to 11.256% of the paid-up capital of the corporate.
In a separate submitting, it had stated LIC’s shareholding in HUL has elevated from 11,73,80,500 to 11,76,90,500 fairness shares, aggregating to five.008% of the paid-up capital of the corporate.
Apart from, LIC’s shareholding in Capri World Capital has elevated from 88,58,348 fairness shares to 1,24,00,000 fairness shares or from 5.043% to 7.059%.
Shares of LIC on Thursday closed at ₹669.20 apiece on BSE, down by 3.08% from its earlier shut whereas Dr Reddy’s Laboratories scrip was down 1.08% at ₹4,290.00 apiece on BSE.
[ad_2]
Source link